Who has invested in LTZ Therapeutics?

K2 Venture Partners, Qiming Venture Partners are named among the investors backing LTZ Therapeutics.

LTZ Therapeutics Funding: $130M Raised, Series A (2022)

LTZ Therapeutics funding overview

LTZ Therapeutics is based in Palo Alto, California. LTZ Therapeutics has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for LTZ Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include K2 Venture Partners, Qiming Venture Partners. 2 distinct backers are named across the disclosed rounds.

LTZ Therapeutics at a glance

Total raised: $130M
Latest round: Series A
Latest round date: April 2022
Headquarters: Palo Alto, California
Notable investors: K2 Venture Partners, Qiming Venture Partners

Frequently asked about LTZ Therapeutics funding

How much has LTZ Therapeutics raised?: LTZ Therapeutics has raised $130M in total disclosed funding across the rounds on record.
Who has invested in LTZ Therapeutics?: K2 Venture Partners, Qiming Venture Partners are named among the investors backing LTZ Therapeutics.
What was the latest LTZ Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2022.
Where is LTZ Therapeutics based?: LTZ Therapeutics is based in Palo Alto, California.
When did LTZ Therapeutics last raise?: The last disclosed LTZ Therapeutics round closed in April 2022 at Series A.

We update the LTZ Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Palo Alto and their backers are listed below.

LTZ Therapeutics Funding: $130M Raised, Series A (2022)

LTZ Therapeutics funding overview

LTZ Therapeutics at a glance

Frequently asked about LTZ Therapeutics funding

Companies related to LTZ Therapeutics (22)

Browse related funding lists (6)